Brenton Harold Zettl, President & Chief Executive Officer at CanniMed Therapeutics Inc, holds 34.58M shares in ZYUS Life Sciences (Ticker: TSE:ZYUS), holds 2.13M shares in CanniMed Therapeutics Inc (Ticker: CMMDF). Most recently, Brenton Harold Zettl Bought ― shares of ZYUS Life Sciences on Feb 01, 2024 for an estimated value of 169.28K.